oncology

By Laura Lovett 03:41 pm January 7, 2020
Oncology management platform OncoLens landed $2.5 million n a Pre-Series A round led by Atlanta Technology Angels and the Robbins Fund yesterday.  This news comes less than a year after the Atlanta-based startup announced a $1.35, which was also led by Atlanta Technology Angles, as well as BIP Capital.  WHAT THEY DO The startup has designed a platform that connects the care teams of patients with...
By Laura Lovett 01:43 pm December 18, 2019
This morning the AI-enabled diagnostic and treatment platform Paige, formerly called Paige.AI, announced a $45 million Series B funding round. The latest raise was led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu and other funders.  Today the company has $70 million in investments. This latest round comes roughly two years after the company closed a $25...

Above photo: Dr. Min-Han Tan, founder and CEO of Lucence. Credit: Lucence

By Dean Koh 02:14 am November 20, 2019
Singapore-headquartered genomic medicine startup Lucence announced it has raised $20 million in Series A funding. The round was led by IHH Healthcare, one of the world’s largest integrated private healthcare groups, with 80 hospitals in 10 countries worldwide. Other participants include SGInnovate, existing investors Heliconia Capital, a subsidiary of Temasek Holdings, Lim Kaling and Koh Boon...
By Tammy Lovell 05:57 am November 13, 2019
Health tech manufacturer Phillips-Medisize has announced the opening of a global innovation and development centre in Copenhagen, Denmark to support its long-term growth plans for advanced injection, wearable devices and connected technologies. The Molex company says it plans for the centre, based in the Teknikerbyen area, to help accelerate the creation of differentiated drug delivery devices...

Credit: Bayer AG

By Leontina Postelnicu 08:14 am October 14, 2019
German pharma giant Bayer has announced this month that it will be working with 11 additional startups to accelerate the development of digital products improving patients’ health through its G4A Digital Health Partnerships programme. The startups, which look at oncology, cardiovascular diseases and others, were selected from over 750 applications spanning 65 countries based on the development...
By Dave Muoio 03:30 pm August 6, 2019
Paris, France-based Voluntis has received FDA marketing authorization for an algorithm-driven digital tool that helps cancer patients manage their symptoms and care teams identify clinical insights, the company announced last week. The Oleena software is a Class II medical device that is prescribed by the patient’s care team. As the user logs their symptoms into the app, it adapts to offer...

Credit: Flow

By Leontina Postelnicu 07:49 am July 24, 2019
Malmö-based medical device startup Flow has landed $1.5m (approximately €1.35m) in funding in a round led by Khosla Ventures, it was announced this week. The new funds will be used to support the European rollout of Flow's brain stimulation headset and therapy app, developed to treat depression, which were launched in the UK and Sweden earlier this year. “The Khosla Ventures investment will...
By Leontina Postelnicu 08:01 am May 23, 2019
It is well-known that there are some situations in which physicians continue to resist the use of mobile health solutions, and a recent study published in JMIR at the beginning of May sought to identify some of the factors that play a key role in the adoption of a free oncology decision support app.  Oncology is a growing space in digital health. CE-approved ONCOassist, launched in 2012, gives...

Inside the wearable device, the blood pump sits in the upper left corner while the heparin injector runs the length of the near side of the box. The green circuit boards control the blood pump, heparin injector and provide display data. Photo Credit: Tae Hyun Kim

By Dave Muoio 12:19 pm April 1, 2019
In an open Nature Communications paper published today, researchers from the University of Michigan described a prototype wearable device that could continuously collect bloodborne cancer cells often used as a biomarker for treatment. Currently, blood draws are required to identify and examine circulating tumor cells (CTCs), and are often limited by inconsistent CTC counts as well as the health...

Above: Screengrab of Burning Rock's website.

By Dean Koh 04:30 am February 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital. The...